Primary frontal sinus squamous cell carcinoma in three dogs treated with piroxicam combined with carboplatin or toceranib.

Item

http://www.wikidata.org/entity/Q48717787

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Primary frontal sinus squamous ...... with carboplatin or toceranib.

@en

Primary frontal sinus squamous ...... with carboplatin or toceranib.

@nl

type

Item

label

Primary frontal sinus squamous ...... with carboplatin or toceranib.

@en

Primary frontal sinus squamous ...... with carboplatin or toceranib.

@nl

prefLabel

Primary frontal sinus squamous ...... with carboplatin or toceranib.

@en

Primary frontal sinus squamous ...... with carboplatin or toceranib.

@nl

P1476

Primary frontal sinus squamous ...... with carboplatin or toceranib.

@en

P2093

E Noorman

http://www.w3.org/2001/XMLSchema#string

J de Vos

http://www.w3.org/2001/XMLSchema#string

P de Vos

http://www.w3.org/2001/XMLSchema#string

S Ramos Vega

http://www.w3.org/2001/XMLSchema#string

P2860

Phase II study of sunitinib malate in head and neck squamous cell carcinoma.

Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study

Prolonged neoadjuvant treatment in locally advanced tumours: a novel concept based on biological considerations.

Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review.

Frontal sinus cancer resection and reconstruction

Augmentation of radiation response by motesanib, a multikinase inhibitor that targets vascular endothelial growth factor receptors.

Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis.

Intra-arterial cisplatin and concomitant radiation therapy followed by surgery for advanced paranasal sinus cancer.

Concurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous carcinoma of the head and neck: consensus, controversy, and conundrum.

Role of epidermal growth factor receptor pathway-targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.

P304

206-213

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1476-5829.2011.00292.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22236048

http://www.w3.org/2001/XMLSchema#string

P921

frontal sinus squamous cell carcinoma